Anthony Brade

Anthony Brade MD, CM, PhD, FRCPC
Assistant Professor
Radiation Oncologist
Contact Info
T: (905) 813-1100 4803
F: (905) 813-3962
Carlo Fidani Peel Regional Cancer Centre - Credit Valley Hospital
Mississauga Halton Central West Regional Cancer Program, Department of Radiation Oncology
2200 Eglington Ave West
Mississauga, ON, L5M 2N1
Please contact Faculty Member for more information
MSc, McMaster University
MD, CM McGill University
PhD, University of Toronto
FRCPC, Radiation Oncology
Assistant Professor, Department of Radiation Oncology, University of Toronto

Publications and Awards

View PubMed search of this faculty member's recent publications.

Recent Publications

You B, Brade A, Magalhaes JM, Siu LL, Oza A, Lovell S, Wang L, Hedley DW, Nicacio LV, Chen EX. A dose-escalation phase I trial of nimotuzumab, an antibody against the epidermal growth factor receptor, in patients with advanced solid malignancies. Invest New Drugs, 2010

Bebb G, Smith C, Rorke S, Boland W, Nicacio L, Sukhoo R, Brade A. Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy. Cancer Chemother Pharmacol, 2010

Brade A, Bezjak A, Macrae R, Laurie S, Sun A, Cho J, Leighl N, Pearson S, Southwood B, Wang L, McGill S, Iscoe N, Shepherd FA. Phase I Trial of Radiation with Concurrent and Consolidation Pemetrexed and Cisplatin in Patients with Unresectable Stage IIIA/B Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys, 2010

Higgins J, Bezjak A, Hope A, Panzarella T, Li W, Cho JB, Craig T, Brade A, Sun A, Bissonnette JP. Effect of Image-Guidance Frequency on Geometric Accuracy and Setup Margins in Radiotherapy for Locally Advanced Lung Cancer. Int J Radiat Oncol Biol Phys, 2010

Giuliani M, Sun A, Bezjak A, Ma C, Le LW, Brade A, Cho J, Leighl NB, Shepherd FA, Hope AJ. Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. Cancer. 116(24):5694-9. doi: 10.1002/cncr.25341, 2010

Li W, Purdie TG, Taremi M, Fung S, Brade A, Cho BC, Hope A, Sun A, Jaffray DA, Bezjak A, Bissonnette JP. Effect of Immobilization and Performance Status on Intrafraction Motion for Stereotactic Lung Radiotherapy: Analysis of 133 Patients. Int J Radiat Oncol Biol Phys, 2010

Dahele M, Freeman M, Pearson S, Brade A, Cho BC, Hope A, Franks K, Purdie T, Bissonnette JP, Jaffray DA, Bezjak A, Sun A. Early Metabolic Response Evaluation After Stereotactic Radiotherapy for Lung Cancer: Pilot Experience with 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography. Clin Oncol (R Coll Radiol), 2010

Coate LE, Massey C, Hope A, Sacher A, Barrett K, Pierre A, Leighl N, Brade A, de Perrot M, Waddell T, Liu G, Feld R, Burkes R, Cho BC, Darling G, Sun A, Keshavjee S, Bezjak A, Shepherd FA. Treatment of the Elderly When Cure is the Goal: The Influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer. J Thorac Oncol. 6(3):537-44, 2011

Lim G, Bezjak A, Higgins J, Moseley D, Hope AJ, Sun A, Cho JB, Brade AM, Ma C, Bissonnette JP. Tumor Regression and Positional Changes in Non-small Cell Lung Cancer During Radical Radiotherapy. J Thorac Oncol. 6(3):531-6, 2011